Zadnji put ažurirano :
19/11/2024
narkotizirajuće djelovanje pomoću kurarina   Suxamethonium chloride  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Actirelax Argentina
Anectine Irska, Meksiko, S A D, Španjolska, Ujedinjeni Arapski Emirati, Velika Britanija
Celocurin Švedska
Celocurine Belgija, Francuska
Chlorsucillin Poljska
Cholsuxinyl Egipat
Cloruro de succinilcolina Argentina
Cloruro de suxametonio Peru
Curacit Norveška
Distensil Peru
Entubate Indija
Ethicoline Malezija
Fosfitone Argentina, Venecuela
Lycitrope Grčka
Lysthenon Austrija, Njemačka, Rumunjska, Saudijska Arabija, Švicarska, Ujedinjeni Arapski Emirati
Midarine Italija, Saudijska Arabija, Švicarska
Mioflex Portugal, Španjolska
Miokolin Iran
Myoplegine Belgija, Luksemburg
Myotenlis Italija
Pantolax Njemačka
Quelicin Kolumbija
Succi Argentina
Succinilcholina Argentina
Succinilcholina cloruro Peru
Succinolin Švicarska
Succinyl Luksemburg
Succinylcholine Iran, Kanada, Njemačka
Succyl Iran
Sukolin Finska
Suxamethonium Australija, Iran, Irska, Malezija, novi Zeland, Velika Britanija
Suxametonio cloruro Čile, Peru
Suxim Peru
Uxicolin Kolumbija, Meksiko
Bibliografija   injekcija   Bibliografija : Suxamethonium chloride  
Vrsta Publikacija
45 Časopis Schmutz CW, Mühlbach SF.
Stability of succinylcholine chloride injection.
Am J Hosp Pharm 1991 ; 48: 501-506.
300 Časopis Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319 Časopis Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
667 Časopis Pramar YV, Moniz D, Hobbs D.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
J Clin Pharm Ther 1994 ; 19: 195-198.
1050 Časopis Boehm JJ, Dutton DM, Poust RI.
Shelf life of unrefrigerated succinylcholine chloride injection.
Am J Hosp Pharm 1984 ; 41: 300-302.
1721 Časopis Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1755 Časopis Storms ML, Stewart JT, Warren FW.
Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2003 ; 7: 68-70.
2215 Časopis Boehm J.J, Poust R.I.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
2227 Časopis Trusley C, Ben M, Kupiec TC, Trissel LA.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 2: 156-160.
2360 Časopis Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
Room temperature stability of injectable succinylcholine dichloride.
Int J Pharm Compound 2008 ; 12, 1: 83-85.
3373 Časopis Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3631 Laboratorija Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3932 Laboratorija Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4274 Časopis Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
J Clin Anesth 2016 ; 35: 551-559.
4528 Časopis Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61

  Mentions Légales